Skip to main content

Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).

Publication ,  Journal Article
Ruwald, A-C; Schuger, C; Moss, AJ; Kutyifa, V; Olshansky, B; Greenberg, H; Cannom, DS; Estes, NAM; Ruwald, MH; Huang, DT; Klein, H; McNitt, S ...
Published in: Circ Arrhythm Electrophysiol
October 2014

BACKGROUND: The benefit of novel implantable cardioverter defibrillator (ICD) programming in reducing inappropriate ICD therapy and mortality was demonstrated in Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). However, the cause of mortality reduction remains incompletely evaluated. We aimed to identify factors associated with mortality, with focus on ICD therapy and programming in the MADIT-RIT population. METHODS AND RESULTS: In MADIT-RIT, 1500 patients with a primary prophylactic indication for ICD or cardiac resynchronization therapy with defibrillator were randomized to 1 of 3 different ICD programming arms: conventional programming (ventricular tachycardia zone ≥170 beats per minute), high-rate programming (ventricular tachycardia zone ≥200 beats per minute), and delayed programming (60-second delay before therapy ≥170 beats per minute). Multivariate Cox models were used to assess the influence of time-dependent appropriate and inappropriate ICD therapy (shock and antitachycardia pacing) and randomized programming arm on all-cause mortality. During an average follow-up of 1.4±0.6 years, 71 of 1500 (5%) patients died: cardiac in 40 patients (56.3%), noncardiac in 23 patients (32.4%), and unknown in 8 patients (11.3%). Appropriate shocks (hazard ratio, 6.32; 95% confidence interval, 3.13-12.75; P<0.001) and inappropriate therapy (hazard ratio, 2.61; 95% confidence interval, 1.28-5.31; P=0.01) were significantly associated with an increased mortality risk. There was no evidence of increased mortality risk in patients who experienced appropriate antitachycardia pacing only (hazard ratio, 1.02; 95% confidence interval, 0.36-2.88; P=0.98). Randomization to conventional programming was identified as an independent predictor of death when compared with patients randomized to high-rate programming (hazard ratio, 2.0; 95% confidence interval, 1.06-3.71; P=0.03). CONCLUSIONS: In MADIT-RIT, appropriate shocks, inappropriate ICD therapy, and randomization to conventional ICD programming were independently associated with an increased mortality risk. Appropriate antitachycardia pacing was not related to an adverse outcome. CLINICAL TRIAL REGISTRATION URL: clinicaltrials.gov Unique identifier: NCT00947310.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circ Arrhythm Electrophysiol

DOI

EISSN

1941-3084

Publication Date

October 2014

Volume

7

Issue

5

Start / End Page

785 / 792

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Time Factors
  • Tachycardia, Ventricular
  • Risk Factors
  • Prosthesis Failure
  • Prosthesis Design
  • Proportional Hazards Models
  • Multivariate Analysis
  • Middle Aged
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ruwald, A.-C., Schuger, C., Moss, A. J., Kutyifa, V., Olshansky, B., Greenberg, H., … Daubert, J. P. (2014). Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Circ Arrhythm Electrophysiol, 7(5), 785–792. https://doi.org/10.1161/CIRCEP.114.001623
Ruwald, Anne-Christine, Claudio Schuger, Arthur J. Moss, Valentina Kutyifa, Brian Olshansky, Henry Greenberg, David S. Cannom, et al. “Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).Circ Arrhythm Electrophysiol 7, no. 5 (October 2014): 785–92. https://doi.org/10.1161/CIRCEP.114.001623.
Ruwald A-C, Schuger C, Moss AJ, Kutyifa V, Olshansky B, Greenberg H, et al. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Circ Arrhythm Electrophysiol. 2014 Oct;7(5):785–92.
Ruwald, Anne-Christine, et al. “Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).Circ Arrhythm Electrophysiol, vol. 7, no. 5, Oct. 2014, pp. 785–92. Pubmed, doi:10.1161/CIRCEP.114.001623.
Ruwald A-C, Schuger C, Moss AJ, Kutyifa V, Olshansky B, Greenberg H, Cannom DS, Estes NAM, Ruwald MH, Huang DT, Klein H, McNitt S, Beck CA, Goldstein R, Brown MW, Kautzner J, Shoda M, Wilber D, Zareba W, Daubert JP. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Circ Arrhythm Electrophysiol. 2014 Oct;7(5):785–792.

Published In

Circ Arrhythm Electrophysiol

DOI

EISSN

1941-3084

Publication Date

October 2014

Volume

7

Issue

5

Start / End Page

785 / 792

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Time Factors
  • Tachycardia, Ventricular
  • Risk Factors
  • Prosthesis Failure
  • Prosthesis Design
  • Proportional Hazards Models
  • Multivariate Analysis
  • Middle Aged